Homepharmaceuticals

pharmaceuticals

Pfizer Stock Forecast: Pfizer Explains How Increased Revenue Will Make Up for Its Patent Shortcomings

Pfizer Stock Forecast: Pfizer Explains How Increased Revenue Will Make Up for Its Patent Shortcomings

December 13, 2022

Pfizer Stock up as Pfizer/Biontech and Moderna Updated Boosters Are Approved for Use in the US in Children as Young as 6 Months

Pfizer Stock up as Pfizer/Biontech and Moderna Updated Boosters Are Approved for Use in the US in Children as Young as 6 Months

December 8, 2022

Pfizer Stock Rises as Omicron Boosters Deemed Less Effective Than New COVID Types – Study

Pfizer Stock Rises as Omicron Boosters Deemed Less Effective Than New COVID Types – Study

December 8, 2022

GSK Stock Fell after Bank of America Downgraded It to Underperform

GSK Stock Fell after Bank of America Downgraded It to Underperform

December 5, 2022

Merck Stock Went Up as It Relied on a New Formulation of Keytruda to Avoid a Patent Cliff

Merck Stock Went Up as It Relied on a New Formulation of Keytruda to Avoid a Patent Cliff

December 2, 2022

Pfizer Stock Rises, to Spend Over €1.2 Billion to Increase Belgium’s Manufacturing Capacity

Pfizer Stock Rises, to Spend Over €1.2 Billion to Increase Belgium’s Manufacturing Capacity

December 2, 2022

Merck Stock Is Rallying, Sending a Historically Bullish Signal

Merck Stock Is Rallying, Sending a Historically Bullish Signal

November 29, 2022

Pfizer Aims for a First in Respiratory Drug, but Is Pfizer Stock a Buy or a Sell?

Pfizer Aims for a First in Respiratory Drug, but Is Pfizer Stock a Buy or a Sell?

November 1, 2022

Pfizer Boosts COVID Vaccine Sales Forecast by $2 Billion

Pfizer Boosts COVID Vaccine Sales Forecast by $2 Billion

November 1, 2022

The Top 5 Stocks to Watch on Tuesday: Uber, Pfizer, Molson Coors, Among Others

The Top 5 Stocks to Watch on Tuesday: Uber, Pfizer, Molson Coors, Among Others

November 1, 2022

« 1 … 3 4 5 6 7 … 16 »